US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist
  • 2.8000
  • -0.1200-4.11%
Close Nov 8 16:00 ET
  • 2.8000
  • 0.00000.00%
Post 17:16 ET
3.75MMarket Cap-2828P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-324.19%-912K
61.02%-2.4M
106.23%152K
-217.24%-1.1M
32.73%-1.23M
85.98%-215K
-44.82%-6.15M
-74.98%-2.44M
-6.75%-348K
-40.34%-1.83M
Net income from continuing operations
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
Operating gains losses
----
----
----
----
----
----
99.86%-1K
----
----
----
Depreciation and amortization
-13.33%39K
40.80%176K
20.59%41K
40.63%45K
60.71%45K
45.16%45K
-32.80%125K
-30.61%34K
-13.51%32K
-46.15%28K
Deferred tax
35.56%122K
-194.59%-109K
-197.10%-201K
----
----
325.00%90K
95.54%-37K
--207K
----
----
Other non cash items
-30.38%55K
-6.94%161K
----
----
----
--79K
-22.42%173K
----
----
----
Change In working capital
-111.33%-92K
187.72%1.69M
169.81%1.15M
-132.99%-515K
124.85%247K
195.42%812K
-161.64%-1.93M
-150.24%-1.65M
131.26%1.56M
-69.05%-994K
-Change in receivables
-346.07%-470K
-5,650.00%-230K
93.23%-9K
-306.23%-596K
311.49%184K
361.64%191K
-100.20%-4K
-106.55%-133K
-46.18%289K
81.99%-87K
-Change in inventory
-149.57%-114K
--184K
70.99%277K
-274.04%-496K
163.60%173K
231.43%230K
--0
-39.10%162K
166.90%285K
-494.20%-272K
-Change in prepaid assets
170.24%59K
461.76%1.11M
163.90%561K
185.14%499K
-72.30%131K
-10.53%-84K
33.48%-306K
-52.96%-878K
-55.92%175K
785.51%473K
-Change in payables and accrued expense
-6.98%480K
163.34%216K
116.53%98K
-85.13%101K
52.88%-499K
-18.35%516K
-138.66%-341K
-189.71%-593K
534.58%679K
-2,202.17%-1.06M
-Change in other current assets
----
----
----
-72.60%20K
----
----
----
----
1.39%73K
-211.11%-10K
-Change in other current liabilities
30.38%-55K
6.94%-161K
21.52%-62K
71.83%-20K
--0
15.96%-79K
22.07%-173K
-2.60%-79K
0.00%-71K
987.50%71K
-Change in other working capital
-78.95%8K
152.17%577K
1,335.48%383K
-117.56%-23K
262.73%179K
103.47%38K
-204.34%-1.11M
-102.77%-31K
122.03%131K
-83.33%-110K
Cash from discontinued investing activities
Operating cash flow
-324.19%-912K
61.02%-2.4M
106.23%152K
-217.24%-1.1M
32.73%-1.23M
85.98%-215K
-44.82%-6.15M
-74.98%-2.44M
-6.75%-348K
-40.34%-1.83M
Investing cash flow
Cash flow from continuing investing activities
70.59%-5K
99.22%-2K
121.95%18K
-102.94%-1K
98.93%-2K
26.09%-17K
-160.61%-258K
-34.43%-82K
34K
-1,800.00%-187K
Net PPE purchase and sale
70.59%-5K
93.68%-17K
101.58%3K
96.77%-1K
92.00%-2K
26.09%-17K
-96.35%-269K
-206.45%-190K
-3,000.00%-31K
0.00%-25K
Net other investing changes
----
36.36%15K
----
----
----
----
-71.05%11K
10,700.00%108K
6,400.00%65K
----
Cash from discontinued investing activities
Investing cash flow
70.59%-5K
99.22%-2K
121.95%18K
-102.94%-1K
98.93%-2K
26.09%-17K
-160.61%-258K
-34.43%-82K
--34K
-1,800.00%-187K
Financing cash flow
Cash flow from continuing financing activities
571.11%636K
-32.66%1.68M
-81.55%622K
514.47%1.32M
27.53%-129K
65.12%-135K
-66.35%2.49M
1,418.92%3.37M
-168.68%-318K
-102.57%-178K
Net issuance payments of debt
8.46%-119K
46.20%-481K
6.00%-94K
44.10%-128K
40.00%-129K
62.86%-130K
-139.04%-894K
-145.05%-100K
-15.08%-229K
-8.59%-215K
Net common stock issuance
15,060.00%748K
-37.80%1.78M
-88.21%338K
--1.45M
--0
---5K
-62.03%2.87M
--2.87M
--0
--0
Proceeds from stock option exercised by employees
--7K
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
-27.57%373K
-37.42%378K
----
----
----
--515K
--604K
----
----
Cash from discontinued financing activities
Financing cash flow
571.11%636K
-32.66%1.68M
-81.55%622K
514.47%1.32M
27.53%-129K
65.12%-135K
-66.35%2.49M
1,418.92%3.37M
-168.68%-318K
-102.57%-178K
Net cash flow
Beginning cash position
-18.12%3.13M
-48.35%3.82M
-8.66%2.41M
-36.23%2.14M
-36.56%3.54M
-48.35%3.82M
75.26%7.4M
-69.12%2.63M
-60.07%3.35M
98.72%5.59M
Current changes in cash
23.43%-281K
81.54%-724K
-6.71%792K
133.70%213K
37.95%-1.36M
81.11%-367K
-228.60%-3.92M
168.80%849K
-561.31%-632K
-139.01%-2.2M
Effect of exchange rate changes
-383.52%-258K
-90.72%32K
-120.77%-70K
165.88%56K
-12.50%-45K
-31.58%91K
171.65%345K
233.66%337K
---85K
13.04%-40K
End cash Position
-26.95%2.59M
-18.12%3.13M
-18.12%3.13M
-8.66%2.41M
-36.23%2.14M
-36.56%3.54M
-48.35%3.82M
-48.35%3.82M
-69.12%2.63M
-60.07%3.35M
Free cash flow
-295.26%-917K
62.39%-2.42M
105.89%155K
-191.56%-1.11M
33.53%-1.23M
85.09%-232K
-46.43%-6.42M
-80.58%-2.63M
-15.90%-379K
-39.58%-1.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -324.19%-912K61.02%-2.4M106.23%152K-217.24%-1.1M32.73%-1.23M85.98%-215K-44.82%-6.15M-74.98%-2.44M-6.75%-348K-40.34%-1.83M
Net income from continuing operations 19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M-917.00%-1.02M
Operating gains losses ------------------------99.86%-1K------------
Depreciation and amortization -13.33%39K40.80%176K20.59%41K40.63%45K60.71%45K45.16%45K-32.80%125K-30.61%34K-13.51%32K-46.15%28K
Deferred tax 35.56%122K-194.59%-109K-197.10%-201K--------325.00%90K95.54%-37K--207K--------
Other non cash items -30.38%55K-6.94%161K--------------79K-22.42%173K------------
Change In working capital -111.33%-92K187.72%1.69M169.81%1.15M-132.99%-515K124.85%247K195.42%812K-161.64%-1.93M-150.24%-1.65M131.26%1.56M-69.05%-994K
-Change in receivables -346.07%-470K-5,650.00%-230K93.23%-9K-306.23%-596K311.49%184K361.64%191K-100.20%-4K-106.55%-133K-46.18%289K81.99%-87K
-Change in inventory -149.57%-114K--184K70.99%277K-274.04%-496K163.60%173K231.43%230K--0-39.10%162K166.90%285K-494.20%-272K
-Change in prepaid assets 170.24%59K461.76%1.11M163.90%561K185.14%499K-72.30%131K-10.53%-84K33.48%-306K-52.96%-878K-55.92%175K785.51%473K
-Change in payables and accrued expense -6.98%480K163.34%216K116.53%98K-85.13%101K52.88%-499K-18.35%516K-138.66%-341K-189.71%-593K534.58%679K-2,202.17%-1.06M
-Change in other current assets -------------72.60%20K----------------1.39%73K-211.11%-10K
-Change in other current liabilities 30.38%-55K6.94%-161K21.52%-62K71.83%-20K--015.96%-79K22.07%-173K-2.60%-79K0.00%-71K987.50%71K
-Change in other working capital -78.95%8K152.17%577K1,335.48%383K-117.56%-23K262.73%179K103.47%38K-204.34%-1.11M-102.77%-31K122.03%131K-83.33%-110K
Cash from discontinued investing activities
Operating cash flow -324.19%-912K61.02%-2.4M106.23%152K-217.24%-1.1M32.73%-1.23M85.98%-215K-44.82%-6.15M-74.98%-2.44M-6.75%-348K-40.34%-1.83M
Investing cash flow
Cash flow from continuing investing activities 70.59%-5K99.22%-2K121.95%18K-102.94%-1K98.93%-2K26.09%-17K-160.61%-258K-34.43%-82K34K-1,800.00%-187K
Net PPE purchase and sale 70.59%-5K93.68%-17K101.58%3K96.77%-1K92.00%-2K26.09%-17K-96.35%-269K-206.45%-190K-3,000.00%-31K0.00%-25K
Net other investing changes ----36.36%15K-----------------71.05%11K10,700.00%108K6,400.00%65K----
Cash from discontinued investing activities
Investing cash flow 70.59%-5K99.22%-2K121.95%18K-102.94%-1K98.93%-2K26.09%-17K-160.61%-258K-34.43%-82K--34K-1,800.00%-187K
Financing cash flow
Cash flow from continuing financing activities 571.11%636K-32.66%1.68M-81.55%622K514.47%1.32M27.53%-129K65.12%-135K-66.35%2.49M1,418.92%3.37M-168.68%-318K-102.57%-178K
Net issuance payments of debt 8.46%-119K46.20%-481K6.00%-94K44.10%-128K40.00%-129K62.86%-130K-139.04%-894K-145.05%-100K-15.08%-229K-8.59%-215K
Net common stock issuance 15,060.00%748K-37.80%1.78M-88.21%338K--1.45M--0---5K-62.03%2.87M--2.87M--0--0
Proceeds from stock option exercised by employees --7K------------------0----------------
Net other financing activities -----27.57%373K-37.42%378K--------------515K--604K--------
Cash from discontinued financing activities
Financing cash flow 571.11%636K-32.66%1.68M-81.55%622K514.47%1.32M27.53%-129K65.12%-135K-66.35%2.49M1,418.92%3.37M-168.68%-318K-102.57%-178K
Net cash flow
Beginning cash position -18.12%3.13M-48.35%3.82M-8.66%2.41M-36.23%2.14M-36.56%3.54M-48.35%3.82M75.26%7.4M-69.12%2.63M-60.07%3.35M98.72%5.59M
Current changes in cash 23.43%-281K81.54%-724K-6.71%792K133.70%213K37.95%-1.36M81.11%-367K-228.60%-3.92M168.80%849K-561.31%-632K-139.01%-2.2M
Effect of exchange rate changes -383.52%-258K-90.72%32K-120.77%-70K165.88%56K-12.50%-45K-31.58%91K171.65%345K233.66%337K---85K13.04%-40K
End cash Position -26.95%2.59M-18.12%3.13M-18.12%3.13M-8.66%2.41M-36.23%2.14M-36.56%3.54M-48.35%3.82M-48.35%3.82M-69.12%2.63M-60.07%3.35M
Free cash flow -295.26%-917K62.39%-2.42M105.89%155K-191.56%-1.11M33.53%-1.23M85.09%-232K-46.43%-6.42M-80.58%-2.63M-15.90%-379K-39.58%-1.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Cannabis & Hemp
Cannabis & Hemp
Intraday-1.05%